| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/23/2006 | US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 03/23/2006 | US20060063934 Pyrazole compounds |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/23/2006 | US20060063831 Composition of labdane diterpenes extracted from andrographis paniculata, ufeful for the treatment of autoimmune diseases, and alzheimer disease by activation for ppr-gamma receptors |
| 03/23/2006 | US20060063788 Carbon monoxide dependent guanylyl cyclase modifiers and methods of use |
| 03/23/2006 | US20060063787 Condensed imidazole derivatives |
| 03/23/2006 | US20060063783 Sulphonylpiperidine derivatives containing an alkenyl or alkynyl moiety for use as matrix metalloproteinase inhibitors |
| 03/23/2006 | US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 03/23/2006 | US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 03/23/2006 | US20060063771 CCR5 antagonists useful for treating AIDS |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | US20060063728 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 03/23/2006 | US20060063250 Use of modified novirhabdoviruses to obtain vaccines |
| 03/23/2006 | US20060062807 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 03/23/2006 | US20060062803 a nucleic acid fhaving a first nucleotide sequence encoding nonstructural proteins from attenuated dengue-2 virus vaccine strain PDK-53, and a second nucleotide sequence encoding a structural protein from a second flavivirus; amino acid mutations in the nontstructural proteins; vaccines |
| 03/23/2006 | US20060062789 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia |
| 03/23/2006 | US20060062782 Anti-IgE vaccines |
| 03/23/2006 | US20060062780 Myelin oligodendrocyte glycoprotein; 1st domain: deimmunized, autoreactive antigen specifically recognized by Ig receptors of autoreactive B-cells; 2nd domain: effector molecule capable of interacting with or activating NK-cells, T-cells, macrophages, monocytes or granulocytes; autoimmune diseases |
| 03/23/2006 | US20060062772 Polypeptide delivery system |
| 03/23/2006 | US20060062769 Using nestin-positive pancreatic stem cell to generate insulin producing beta cells; tissue engineering and repair; regenerative medicine |
| 03/23/2006 | US20060062761 Modified interferon alpha with reduced immunogenicity |
| 03/23/2006 | DE4007605B4 SDK-Peptide, Verfahren zu ihrer Herstellung und diese enthaltende therapeutischen Zusammensetzungen SDK peptides, process for their preparation and therapeutic compositions containing |
| 03/23/2006 | CA2581017A1 Compositions monovalent for cd40l binding and methods of use |
| 03/23/2006 | CA2580717A1 Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children. |
| 03/23/2006 | CA2580642A1 Novel tellurium compounds and their use as immunomodulators |
| 03/23/2006 | CA2580517A1 Protein a compositions and methods of use |
| 03/23/2006 | CA2580010A1 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response |
| 03/23/2006 | CA2579501A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 03/23/2006 | CA2578248A1 Multiple sclerosis treatment |
| 03/23/2006 | CA2577133A1 Polypeptide variants with altered effector function |
| 03/22/2006 | EP1637611A1 Method for producing oligosaccharides |
| 03/22/2006 | EP1637591A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoc |
| 03/22/2006 | EP1637533A1 Substituted thiazolopyrimidines as analgetics |
| 03/22/2006 | EP1637531A1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
| 03/22/2006 | EP1637162A1 MEDICINAL COMPOSITION FOR PREVENTING OR TREATING Th1 TYPE IMMUNOLOGICAL DISEASE |
| 03/22/2006 | EP1637160A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 03/22/2006 | EP1637159A1 Immunocompetent cell activation inhibitor and use thereof |
| 03/22/2006 | EP1637158A2 Capsular polysaccharide immunomodulator |
| 03/22/2006 | EP1637155A1 Method of mudulating memory effector T-cells using a CD2-binding agent, and compositions |
| 03/22/2006 | EP1637147A1 Stable dust extract for allergy protection |
| 03/22/2006 | EP1637146A2 Ex vivo treatment of allogeneic and xenogeneic T-cells with gp39 antagonists |
| 03/22/2006 | EP1637139A2 Novel use of HIV protease inhibiting compounds |
| 03/22/2006 | EP1636345A2 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 03/22/2006 | EP1636235A1 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors |
| 03/22/2006 | EP1636234A1 Imidazotriazinone derivatives as pde 7 (phosphodiesterase 7) inhibitors |
| 03/22/2006 | EP1636230A2 A1 adenosine receptor antagonists |
| 03/22/2006 | EP1636229A2 A1 adenosine receptor antogonists |
| 03/22/2006 | EP1636174A1 Inhibitors of matrix metalloproteinase |
| 03/22/2006 | EP1636171A2 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 03/22/2006 | EP1635862A1 Peptides derived from the protein mmp-2, and the use thereof in antitumoral immunotherapy |
| 03/22/2006 | EP1563083A4 Use of cytokines secreted by dendritic cells |
| 03/22/2006 | EP1550460A4 Method for correcting immune responses and medicinal agent |
| 03/22/2006 | EP1480951A4 Synthesis of indole thiazole compounds as ligands for the ah receptor |
| 03/22/2006 | EP1472221B1 Substituted indoles, method for production and use thereof for the inhibition of pain |
| 03/22/2006 | EP1461436A4 Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 03/22/2006 | EP1412357B1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/22/2006 | EP1381620B1 Hypersulfated disaccharides and methods of using the same for the treatment of inflammations |
| 03/22/2006 | EP1368345B1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 03/22/2006 | EP1322287B1 Microparticles for delivery of the heterologous nucleic acids |
| 03/22/2006 | EP1311522B1 New immunoeffector compounds |
| 03/22/2006 | EP1301516B1 Modulators of protein tyrosine phosphatases (ptpases) |
| 03/22/2006 | EP1272488B1 Tri-aryl-substituted-ethane pde4 inhibitors |
| 03/22/2006 | EP1220862B1 Purine derivatives |
| 03/22/2006 | EP1207867B1 Oral pharmaceutical forms of administration with a delayed action with tramadol |
| 03/22/2006 | EP1140924B1 Piperazine derivatives |
| 03/22/2006 | EP1139743B1 Exo-s-mecamylamine formulation and use in treatment |
| 03/22/2006 | EP1005480B1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 03/22/2006 | EP0915700B1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 03/22/2006 | CN1751054A Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators |
| 03/22/2006 | CN1751042A Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 03/22/2006 | CN1751010A Adamantane derivatives, processes for their preparation and pharmaceutical composition containing them |
| 03/22/2006 | CN1750840A Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 03/22/2006 | CN1750816A Composition comprising cysteamine for improving immunity of animals |
| 03/22/2006 | CN1749282A Belly bottom snail polysaccharide and its preparing method |
| 03/22/2006 | CN1748793A Method for preparing cow foremilk immune globulin microcapsulation |
| 03/22/2006 | CN1748788A Recombinant human interferon alpha 26 injection of prefilled injector package |
| 03/22/2006 | CN1748787A Pharmaceutical preparation containing p40 molecule or its gene |
| 03/22/2006 | CN1748785A Water solution preparation of reducing type glutathione, its preparing method and use |
| 03/22/2006 | CN1748767A Lupus preparation and new preparing method |
| 03/22/2006 | CN1748715A Use of Peroplaneta fluligginosa water extract in preparing medicine for anti-inflammatory and immune |
| 03/22/2006 | CN1748713A Process for preparing chick embryo element |
| 03/22/2006 | CN1748699A Albendazole new form for treating allergic rhinitis |
| 03/22/2006 | CN1748694A Albendazole nasal jelly for treating allergic rhinitis |
| 03/22/2006 | CN1748689A Oxibendazole newform for treating alllergic rhinitis |
| 03/22/2006 | CN1748684A Oxibendazole nasal jelly for treating allergic rhinitis |
| 03/22/2006 | CN1748679A Mebendazole new form for treating allergic rhinitis |
| 03/22/2006 | CN1246456C Lactic acid bacteria capable of reducing individual's tendency to develop allergic reactions |
| 03/22/2006 | CN1246337C Novel TNFR-Fc fusion protein |
| 03/22/2006 | CN1246335C Recombinant IL-18 antagonist useful in treatment of IL-18 mediated disorders |
| 03/22/2006 | CN1246312C Antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 03/22/2006 | CN1246311C Pyrrolidines which inhibit CAMP-specific PDE |
| 03/22/2006 | CN1246038C Systemic delivery of oral vaccines of botulinus toxin |
| 03/22/2006 | CN1246035C Medicine composition of macrolides or cyclosporin and polyoxide saturated hydoxy fatty acid |
| 03/22/2006 | CN1245994C Use of salivary lactobacillus |
| 03/22/2006 | CN1245989C Immune activator |
| 03/22/2006 | CN1245978C Preventive or therapeutic drugs for various eosinophilia realated diseases containing chymase inhibitors as active ingredient |
| 03/22/2006 | CN1245975C Medicinal composition for stabilizing delotadine in preparation |
| 03/22/2006 | CN1245955C Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 03/21/2006 | US7015325 Alkyne oxy carbamate derivatives used to treat respiratory system disorders |
| 03/21/2006 | US7015234 Hydroxamic acid derivatives |